Schedule 13G ownership disclosure

Menlo Therapeutics, Inc.

Security class unavailable · CUSIP: 586858102

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.0400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001567619-20-002059
Form type
SC 13G/A
Filer
FIRST MANHATTAN CO. LLC.
CIK
CIK 728083
Filed
Feb 04, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub